FilingReader Intelligence
Nectar Lifesciences revenue jumps 44% in Q1
August 15, 2025 at 06:49 AM UTC•By FilingReader AI
Nectar Lifesciences reported revenue of INR 675.48 million for the quarter ended June 30, 2025, up from INR 469.04 million in the previous quarter.
However, profit fell sharply to INR 300.95 million from INR 2,718.33 million in the March 2025 quarter. Basic and diluted earnings per share stood at INR 0.17.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:NECLIFE•Bombay Stock Exchange
News Alerts
Get instant email alerts when Nectar Lifesciences publishes news
Free account required • Unsubscribe anytime